- £240.10m
- £234.60m
- £12.82m
- 89
- 17
- 65
- 59
Annual cashflow statement for Bioventix, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | UAS | UAS | UAS | UAS | UAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 5.86 | 7.2 | 6.73 | 7.67 | 8.37 |
| Depreciation | |||||
| Non-Cash Items | 1.2 | 1.1 | 1.61 | 1.86 | 1.84 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.25 | -0.752 | -2.14 | -2.12 | -2.53 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 5.88 | 7.68 | 6.34 | 7.56 | 7.8 |
| Capital Expenditures | -0.085 | -0.34 | -0.26 | -0.012 | -0.011 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.062 | -0.181 | 0.031 | 0.005 | 0.101 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.147 | -0.52 | -0.229 | -0.007 | 0.091 |
| Financing Cash Flow Items | 0 | — | — | -0 | 0 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | -6.18 | -5.62 | -7.69 | -7.92 | -8.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.449 | 1.54 | -1.58 | -0.368 | -0.411 |